Lauren P Wallner1,2,3,4, Paul Abrahamse5, Joan G Gargaro6, Archana Radhakrishnan7,5,8, Megan A Mullins5, Lawrence C An7,5,8, Jennifer J Griggs5,9,8,10, Anne F Schott5,9, John Z Ayanian7,8,10, Anne E Sales8,11, Steven Katz7,5,8,10, Sarah T Hawley7,5,6,8,10. 1. Division of General Medicine, Department of Internal Medicine, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building 16, Room 409E, Ann Arbor, MI, 48109-2800, USA. lwallner@med.umich.edu. 2. Department of Epidemiology, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building 16, Room 409E, Ann Arbor, MI, 48109-2800, USA. lwallner@med.umich.edu. 3. Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. lwallner@med.umich.edu. 4. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA. lwallner@med.umich.edu. 5. Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. 6. Ann Arbor VA Center for Clinical Management Research, Ann Arbor, MI, USA. 7. Division of General Medicine, Department of Internal Medicine, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building 16, Room 409E, Ann Arbor, MI, 48109-2800, USA. 8. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA. 9. Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. 10. Department of Health Management and Policy, University of Michigan, Ann Arbor, MI, USA. 11. Department of Learning Health Sciences, Medical School, University of Michigan, Ann Arbor, MI, USA.
Abstract
PURPOSE: We developed and tested a multi-level intervention, ConnectedCancerCare (CCC), which includes a tailored website and appointment reminder system for women with early-stage breast cancer and a provider summary letter sent to their medical oncologist and primary care provider to improve the delivery of team-based survivorship care. METHODS: We conducted a pilot randomized controlled trial to establish the feasibility and acceptability of CCC. Women diagnosed with stages 0-II breast cancer within one year of completing primary treatment were randomized to CCC (intervention) or a static online survivorship care plan (control). Participants completed baseline and 3-month follow-up surveys online. Post-trial interviews with 5 PCPs, 6 oncology providers, and 8 intervention patients were conducted. RESULTS: Of the 160 eligible women invited to participate, 66 completed the baseline survey and were randomized (41%) and 54 completed a follow-up survey (83%). Participants in the intervention arm found the CCC content to be acceptable, with 82% reporting it was easy to use and 86% reporting they would recommend it to other patients. Women randomized to CCC (vs. control) more often reported scheduling a PCP follow-up visit (64% vs. 42%), communicating with their PCP about provider roles (67% vs. 18%), and higher mean team-based cancer care knowledge scores (3.7 vs. 3.4). CONCLUSION: Deploying CCC in medical oncology practices was feasible, and the intervention content was acceptable. CCC shows promise for improving patient knowledge and patient-provider communication about provider roles in team-based cancer care and encouraging patients to engage with their PCP early in the survivorship period.
PURPOSE: We developed and tested a multi-level intervention, ConnectedCancerCare (CCC), which includes a tailored website and appointment reminder system for women with early-stage breast cancer and a provider summary letter sent to their medical oncologist and primary care provider to improve the delivery of team-based survivorship care. METHODS: We conducted a pilot randomized controlled trial to establish the feasibility and acceptability of CCC. Women diagnosed with stages 0-II breast cancer within one year of completing primary treatment were randomized to CCC (intervention) or a static online survivorship care plan (control). Participants completed baseline and 3-month follow-up surveys online. Post-trial interviews with 5 PCPs, 6 oncology providers, and 8 intervention patients were conducted. RESULTS: Of the 160 eligible women invited to participate, 66 completed the baseline survey and were randomized (41%) and 54 completed a follow-up survey (83%). Participants in the intervention arm found the CCC content to be acceptable, with 82% reporting it was easy to use and 86% reporting they would recommend it to other patients. Women randomized to CCC (vs. control) more often reported scheduling a PCP follow-up visit (64% vs. 42%), communicating with their PCP about provider roles (67% vs. 18%), and higher mean team-based cancer care knowledge scores (3.7 vs. 3.4). CONCLUSION: Deploying CCC in medical oncology practices was feasible, and the intervention content was acceptable. CCC shows promise for improving patient knowledge and patient-provider communication about provider roles in team-based cancer care and encouraging patients to engage with their PCP early in the survivorship period.
Authors: Laura P Forsythe; Carla Parry; Catherine M Alfano; Erin E Kent; Corinne R Leach; David A Haggstrom; Patricia A Ganz; Noreen Aziz; Julia H Rowland Journal: J Natl Cancer Inst Date: 2013-10-04 Impact factor: 13.506
Authors: Julienne E Bower; Patricia A Ganz; Katherine A Desmond; Coen Bernaards; Julia H Rowland; Beth E Meyerowitz; Thomas R Belin Journal: Cancer Date: 2006-02-15 Impact factor: 6.860
Authors: Lauren P Wallner; Yun Li; Allison K C Furgal; Christopher R Friese; Ann S Hamilton; Kevin C Ward; Reshma Jagsi; Steven J Katz; Sarah T Hawley Journal: J Clin Oncol Date: 2017-07-12 Impact factor: 50.717
Authors: Brian L Sprague; Kim L Dittus; Claire M Pace; Dorothy Dulko; Lori A Pollack; Nikki A Hawkins; Berta M Geller Journal: Clin J Oncol Nurs Date: 2013-06 Impact factor: 1.027
Authors: Lauren P Wallner; Paul Abrahamse; Jaspreet K Uppal; Christopher R Friese; Ann S Hamilton; Kevin C Ward; Steven J Katz; Sarah T Hawley Journal: J Clin Oncol Date: 2016-10-31 Impact factor: 50.717
Authors: Archana Radhakrishnan; M Chandler McLeod; Ann S Hamilton; Kevin C Ward; Steven J Katz; Sarah T Hawley; Lauren P Wallner Journal: J Gen Intern Med Date: 2019-02 Impact factor: 5.128
Authors: Archana Radhakrishnan; Yun Li; Allison K C Furgal; Ann S Hamilton; Kevin C Ward; Reshma Jagsi; Steven J Katz; Sarah T Hawley; Lauren P Wallner Journal: J Oncol Pract Date: 2019-03-11 Impact factor: 3.714
Authors: Madeleine Love; Marc Debay; Anne Charity Hudley; Todd Sorsby; Linda Lucero; Stuart Miller; Sagus Sampath; Arya Amini; Dan Raz; Jae Kim; Ranjan Pathak; Yi-Jen Chen; Andreas Kaiser; Kurt Melstrom; Marwan Fakih; Virginia Sun Journal: J Prim Care Community Health Date: 2022 Jan-Dec
Authors: Deanna J Attai; Matthew S Katz; Elani Streja; Jui-Ting Hsiung; Maria V Marroquin; Beverly A Zavaleta; Larissa Nekhlyudov Journal: J Cancer Surviv Date: 2022-02-03 Impact factor: 4.442